Whitehawk Therapeutics WHWK
NASDAQ WHWK
$4.60 -0.03 (-0.65%)
As of: Sep 4, 2026 · 3:59 PM EDT

Whitehawk Therapeutics (WHWK) EBIT Margin (QoQ) (2018 - 2025)

Analysis

Whitehawk Therapeutics (WHWK) EBIT Margin (QoQ) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Whitehawk Therapeutics 377.13 Mn 377.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 4,877.00
Dec 31, 2024 -7,578.00
Sep 30, 2024 6,623.00
Jun 30, 2024 11,230.00
Mar 31, 2024 -8,449.00
Dec 31, 2023 1,951.00
Sep 30, 2023 1,561.00
Jun 30, 2023 -2,837.00
Mar 31, 2023 923.00
Dec 31, 2022 5,820.00
Sep 30, 2022 17,998.00
Jun 30, 2022 6,460.00
Mar 31, 2022 -48,489.00
Mar 31, 2021 -346,586.00
Dec 31, 2020 121,284.00
Sep 30, 2020 -121,452.00
Dec 31, 2018 -41.36 Mn
Sep 30, 2018 51,223.00